heptakis(2,6-o-dimethyl)beta-cyclodextrin has been researched along with taurocholic acid in 4 studies
| Studies (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Trials (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Recent Studies (post-2010) (heptakis(2,6-o-dimethyl)beta-cyclodextrin) | Studies (taurocholic acid) | Trials (taurocholic acid) | Recent Studies (post-2010) (taurocholic acid) |
|---|---|---|---|---|---|
| 148 | 0 | 45 | 3,789 | 26 | 654 |
| Protein | Taxonomy | heptakis(2,6-o-dimethyl)beta-cyclodextrin (IC50) | taurocholic acid (IC50) |
|---|---|---|---|
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 6 | |
| Sodium/bile acid cotransporter | Rattus norvegicus (Norway rat) | 6 | |
| Sodium/bile acid cotransporter | Homo sapiens (human) | 5.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Celebi, N; Değim, Z; Karamustafa, F; Unal, N | 1 |
| Degim, Z; Eşsiz, D; Mutlu, NB; Nacar, A; Yilmaz, S | 2 |
| Ağardan, NB; Altıntaş, L; Değim, Z; Topal, T; Yılmaz, Ş | 1 |
4 other study(ies) available for heptakis(2,6-o-dimethyl)beta-cyclodextrin and taurocholic acid
| Article | Year |
|---|---|
Transport evaluation of alendronate across Caco-2 cell monolayers.
Topics: Absorption; Alendronate; beta-Cyclodextrins; Biological Transport, Active; Bone Density Conservation Agents; Caco-2 Cells; Cell Membrane Permeability; Cell Survival; Electric Impedance; Excipients; Humans; Taurocholic Acid; Tetrazolium Salts; Thiazoles | 2009 |
Investigation of liposome formulation effects on rivastigmine transport through human colonic adenocarcinoma cell line (CACO-2).
Topics: Absorption; Animals; beta-Cyclodextrins; Biological Transport, Active; Brain; Caco-2 Cells; Cell Survival; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Drug Compounding; Excipients; Humans; Liposomes; Male; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Particle Size; Phenylcarbamates; Rivastigmine; Taurocholic Acid | 2010 |
New perspective for the treatment of Alzheimer diseases: liposomal rivastigmine formulations.
Topics: Alzheimer Disease; Animals; beta-Cyclodextrins; Biological Availability; Brain; Cell Line; Cholinesterase Inhibitors; Dogs; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Stability; Humans; Liposomes; Male; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Neuroprotective Agents; Particle Size; Phenylcarbamates; Rivastigmine; Taurocholic Acid | 2011 |
The Effectiveness of Raloxifene-Loaded Liposomes and Cochleates in Breast Cancer Therapy.
Topics: Animals; Antineoplastic Agents; beta-Cyclodextrins; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Chemistry, Pharmaceutical; Female; Humans; Liposomes; Matrix Metalloproteinase 2; MCF-7 Cells; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Taurocholic Acid | 2016 |